Villa, F.; Crippa, A.; Pelizzoni, D.; Ardizzoia, A.; Scartabellati, G.; Corbetta, C.; Cipriani, E.; Lavitrano, M.; Ardizzoia, A.
Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data. Int. J. Mol. Sci. 2023, 24, 14427.
https://doi.org/10.3390/ijms241914427
AMA Style
Villa F, Crippa A, Pelizzoni D, Ardizzoia A, Scartabellati G, Corbetta C, Cipriani E, Lavitrano M, Ardizzoia A.
Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data. International Journal of Molecular Sciences. 2023; 24(19):14427.
https://doi.org/10.3390/ijms241914427
Chicago/Turabian Style
Villa, Federica, Alessandra Crippa, Davide Pelizzoni, Alessandra Ardizzoia, Giulia Scartabellati, Cristina Corbetta, Eleonora Cipriani, Marialuisa Lavitrano, and Antonio Ardizzoia.
2023. "Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data" International Journal of Molecular Sciences 24, no. 19: 14427.
https://doi.org/10.3390/ijms241914427
APA Style
Villa, F., Crippa, A., Pelizzoni, D., Ardizzoia, A., Scartabellati, G., Corbetta, C., Cipriani, E., Lavitrano, M., & Ardizzoia, A.
(2023). Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data. International Journal of Molecular Sciences, 24(19), 14427.
https://doi.org/10.3390/ijms241914427
